SAN FRANCISCO, Aug. 4, 2021 /PRNewswire/ — Nathan Sassover, Founder / CEO of World Cancer Institute Inc. today announced “further clinical developments in enlarging our targeted medical objectives which originated in 2008 and have evolved to a multiplicity of protocols which continue to be implemented and assessed based on their engagement of processes and molecular/cellular modalities with confirmed […]

SAN FRANCISCO, Aug. 16, 2021 /PRNewswire/ — Nathan Sassover, Founder /CEO of World Cancer Institute provided further views on the health challenges impacting cancer management and prevention dynamics within the escalating COVID 19 virus pandemic. “There are so many overlapping factors and shifting policies and practices announced and  implemented by CDC and FDA to confront the  enlarging impact […]

SAN FRANCISCO–(BUSINESS WIRE)– Nathan Sassover, Founder/ CEO of World Cancer Institute Inc., today announced the evolutionary platform of cancer clinical protocols originating initially in 2008 /2009 based on molecular cancer genetics and DNA programmable pharmaceutics to inhibit the growth, replication and proliferation of human cancer cells. Sassover stated, “CancerVX, (IECT- Intratherapies Epigenetic Cancer Therapeutics) demonstrates progressive […]